Close Menu

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that its first quarter 2019 revenues grew five percent year over year, driven by strong results across all of its business segments.

The company, headquartered in Waltham, Massachusetts, reported Q1revenues of $6.12 billion, up 5 percent from $5.85 billion during the same period last year, beating average expectations by Wall Street analysts of $6.02 billion. Organic revenue growth was 7 percent, acquisitions contributed 1 percent, and currency effects decreased revenue by 3 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.